Iraj Harirchi|Shadi Kolahdoozan|Mojgan Karbakhsh|Najmeh Chegini|Sahar Mohseni|Ali Montazeri|Amir-Javad Momtahen|Amir Kashefi|Mansour Ebrahimi
Twenty years of breast cancer in Iran: downstaging without a formal screening program
Tehran University of Medical Sciences|Cancer Research Center|Cancer Institute (WIA)|Shariati Hospital|Tehran University of Medical Sciences|Tehran University of Medical Sciences|Tehran University of Medical Sciences|Cancer Institute (WIA)|Cancer Research Center|Tehran University of Medical Sciences|Cancer Institute (WIA)|Cancer Research Center|Iranian Institute for Health Sciences Research|Academic Center for Education, Culture and Research|Tehran University of Medical Sciences|Cancer Institute (WIA)|Cancer Research Center|Tehran University of Medical Sciences|Cancer Institute (WIA)|Cancer Research Center|Motamed Cancer Institute
breast cancer bc common malignancy among iranian women although relative incidence bc low causespecific mortality much higher developed countries present study surveyed overall trend bc tehranall breast pathologic records studied five major hospitals tehran three phases 1 19851995 2 19962000 3 20012005 malignant cases classified according tumornodemetastasis classification data compared across studyof 9050 medical records male female patients breast disease 2946 females bc included significant increase diagnosis palpable early bcs stage ii increased stage iii decreased observed phases 1 2 relative increases stages 0 noted phases 3 2 nevertheless 768 cases t2 higher 653 positive lymph nodes last phase proportion patients stage iiib increased phase 3 despite reduction phase 2despite relative improvement status bc patients vast majority diagnosed advanced stages specific screening measures implemented iran